GREGORY SHARP: Open Payments
NPI 1639179898 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,825 in 251 payments from 25 companies in 2025. Trend: 2023 $4,419 · 2024 $4,316 · 2025 $3,825
Food & beverage: $3,627Education: $198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $631 |
| Janssen Biotech, Inc. | 34 | $503 |
| UCB, Inc. | 19 | $394 |
| Novartis Pharmaceuticals Corporation | 23 | $390 |
| Incyte Corporation | 20 | $305 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 22 | $291 |
| Lilly USA, LLC | 12 | $196 |
| GENZYME CORPORATION | 10 | $152 |
| LEO Pharma Inc. | 14 | $151 |
| PFIZER INC. | 11 | $139 |
Products named: TREMFYA, Bimzelx, RINVOQ, OPZELURA, DUPIXENT, SKYRIZI, COSENTYX, EBGLYSS.
Industry payments across AL — which companies pay providers there.
